Clinical Trials in Philadelphia

Showing 7801-7820 of 15,860 trials

COVID-19 Convalescent Plasma for Mechanically Ventilated Population

NCT04388527

The purpose of this study is to see if this plasma can be safely used in humans with COVID-19 and to see if it can improve patients' health when they are sick with COVID-19.

Covid-19

University of Pennsylvania32 participantsStarted Apr 2020

Philadelphia, Pennsylvania, United States

UNKNOWNPhase 2< 1 mile

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

NCT03457896

This is a phase II trial to examine the efficacy of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (all RAS/NRAS/BRAF/PIK3CA wild-type), metastatic colorectal cancer based on HER2 status (amplified, non-amplified \[wild-type\] or mutated). Patients must have confirmed quadruple wild-type (WT) genotype, via NSABP MPR-1 or from colonic biopsy or a metastatic biopsy taken prior to treatment, and known HER2 status.

Metastatic Colorectal Cancer

NSABP Foundation Inc35 participantsStarted May 2018

Anaheim, California, United States • Baldwin Park, California, United States • Bellflower, California, United States +45 more locations

COVID-19 Convalescent Plasma for Mechanically Ventilated Population

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Find Trials by Condition in Philadelphia

Repeat Antenatal Steroids Trial

Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

The National Standard for Normal Fetal Growth

A Study of Oral Contraception Under Simulated OTC Conditions

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Neuroimaging Biomarker for Seizures

Parents Advancing Toddler Health

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.